Related Experiment Video

Updated: Aug 11, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Choosing the right macrolide antibiotic. A guide to selection

L Charles1, J Segreti

  • 1Rush Medical College, Chicago, Illinois, USA.

Drugs
|March 1, 1997
PubMed

Insights

Macrolide antibiotics like azithromycin and clarithromycin offer alternatives to penicillin for various infections. Clarithromycin and azithromycin show improved efficacy against specific bacteria, making them suitable for community-acquired pneumonia.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Macrolide antibiotics are key alternatives to beta-lactam antibiotics for treating bacterial infections.
  • Selection of a macrolide depends on causative organisms, drug tolerability, dosing convenience, and potential drug interactions.

Purpose of the Study:

  • To compare the efficacy and applications of commonly used macrolides, specifically erythromycin, azithromycin, and clarithromycin.
  • To evaluate the suitability of macrolides for treating specific infections like community-acquired pneumonia, Mycobacterium avium complex (MAC), Helicobacter pylori, and Chlamydia trachomatis.

Main Methods:

  • Comparative analysis of macrolide antibiotic profiles.
  • Review of clinical applications and efficacy data for erythromycin, azithromycin, and clarithromycin.
  • Consideration of factors influencing macrolide selection and cost-effectiveness.

Main Results:

  • Erythromycin, azithromycin, and clarithromycin exhibit similar efficacy against Gram-positive organisms.
  • Clarithromycin and azithromycin demonstrate superior activity against Haemophilus influenza and Moraxella catarrhalis, beneficial for community-acquired pneumonia.
  • Azithromycin's low serum concentration may limit its use in bacteremic pneumonia; clarithromycin is preferred for MAC treatment and H. pylori, while azithromycin is preferred for Chlamydia trachomatis.

Conclusions:

  • Clarithromycin and azithromycin are preferred macrolides for community-acquired pneumonia due to enhanced activity against key respiratory pathogens.
  • Macrolide selection requires careful consideration of the specific infection, pathogen profile, and patient factors.
  • Cost remains a limitation, but improved tolerability and dosing convenience of azithromycin and clarithromycin may enhance compliance and cost-effectiveness.

More Related Videos

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance09:59

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance

Published on: July 21, 2023

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...